Preeti Kondal, D.O. Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 3525 Ensign Rd Ne Ste R, Pmg Sw Wa Olympia Infectious Diseases, Olympia, WA 98506 Phone: 360-493-4001 Fax: 360-455-7405 |
Dr. Kristie Janine Lowry, M.D. Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 700 Lilly Rd Ne, Olympia, WA 98506 Phone: 360-923-7000 |
Mordechai Groner, M.D. Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 3525 Ensign Rd Ne Ste F, Olympia, WA 98506 Phone: 360-493-4001 Fax: 360-438-2026 |
Julio C. Gonzalez, M.D. Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 413 Lilly Rd Ne, Olympia, WA 98506 Phone: 360-493-4083 |
Dana R Saunders, M.D. Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 3525 Ensign Rd Ne Ste R, Pmg Sw Wa Olympia Infectious Diseases, Olympia, WA 98506 Phone: 360-493-4001 Fax: 360-438-2026 |
Britta L Denman, DO Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 3920 Capital Mall Dr Sw Ste 402, Olympia, WA 98502 Phone: 360-596-4612 |
Steven M Standaert, M.D. Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 3525 Ensign Rd Ne Ste R, Pmg Sw Wa Olympia Infectious Diseases, Olympia, WA 98506 Phone: 360-493-4001 |
Michael L Matlock, M.D. Internal Medicine - Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 3525 Ensign Rd Ne, Suite 02, Olympia, WA 98506 Phone: 360-459-1213 Fax: 360-459-0114 |
News Archive
The International Association for the Study of Lung Cancer today used the platform of its largest international meeting to call attention to the importance of tobacco cessation after cancer diagnosis, and urged all physicians to screen cancer patients for tobacco use and recommend tobacco cessation.
NeoStem, Inc., an international biopharmaceutical company with operations in the U.S. and China and ImmuneRegen BioSciences, Inc., a wholly owned subsidiary of IR BioSciences Holdings, Inc., announced today that they have entered into a Collaborative Research Agreement, focused on the development of an advanced, adult human stem cell product.
PROLOR Biotech, Inc.,, a company developing next generation biobetter therapeutic proteins, today announced that the Tel Aviv Stock Exchange (TASE) has approved the new listing of PROLOR's common stock on the TASE beginning on Thursday, May 27, 2010. At that time, the company's common stock will be listed on both the NYSE Amex in the United States and the TASE in Israel.
The National Science Foundation has awarded $6 million to researchers in Kentucky, Oklahoma and Rhode Island to develop innovative and broadly accessible brain imaging technologies to provide insight into how the nervous system functions in health and disease.
› Verified 4 days ago